Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 41

Trial Status

Completed2
Recruiting1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT07468877Not ApplicableRecruiting
This Clinical Trial Compares Two Phacoemulsification Systems Used in a Bilateral Cataract Surgery Subjects in Order to Study CDE and Ultrasound Time During Cataract Removal
Cataract BilateralNuclear Sclerosis of the LensPhacoemulsification Cataract Surgery
PrincipalinvestigatorStart date: 2026-02-13
NCT05626478Phase 4Completed
Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery
Anterior Chamber InflammationCME - Cystoid Macular EdemaCorneal Defect+4 more
PrincipalinvestigatorStart date: 2023-06-01
NCT04975971Completed
A Retrospective Review of DEXTENZA 0.4 mg inseRt Following Corneal Transplant or Cataract Surgery
Anterior Chamber InflammationCataract SenileCorneal Defect+5 more
PrincipalinvestigatorStart date: 2021-03-09

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT07468877Not ApplicablePrincipalInvestigator

This Clinical Trial Compares Two Phacoemulsification Systems Used in a Bilateral Cataract Surgery Subjects in Order to Study CDE and Ultrasound Time During Cataract Removal

Cataract BilateralNuclear Sclerosis of the LensPhacoemulsification Cataract Surgery
Recruiting
NCT05626478Phase 4PrincipalInvestigator

Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery

Anterior Chamber InflammationCME - Cystoid Macular EdemaCorneal Defect+4 more
Completed
NCT04975971PrincipalInvestigator

A Retrospective Review of DEXTENZA 0.4 mg inseRt Following Corneal Transplant or Cataract Surgery

Anterior Chamber InflammationCataract SenileCorneal Defect+5 more
Completed

All 3 trials loaded